Kent E. Jardemark
Stockholm, AB 17177, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.
Journal: Annals of the rheumatic diseases
Published: November 18, 2025
Dual cholinergic modulation in dementia: Quinuclidine carbamates targeting butyrylcholinesterase and α7 nicotinic receptor.
Journal: Chemico-biological interactions
Published: September 18, 2025
Kynurenic Acid and Promotion of Activity-Dependent Synapse Elimination in Schizophrenia.
Journal: The American journal of psychiatry
Published: April 01, 2025
Novel druggable space in human KRAS G13D discovered using structural bioinformatics and a P-loop targeting monoclonal antibody.
Journal: Scientific reports
Published: March 11, 2024
Ca2+ and force during dynamic contractions in mouse intact skeletal muscle fibers.
Journal: Scientific reports
Published: September 11, 2023
Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: May 06, 2022
Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice.
Journal: International journal of tryptophan research : IJTR
Published: April 06, 2021
Rational antibody design for undruggable targets using kinetically controlled biomolecular probes.
Journal: Science advances
Published: September 03, 2020
Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons.
Journal: The Journal of experimental medicine
Published: August 30, 2018
The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: August 03, 2016
Last Updated: 09/26/2026